{"id":"antiplatelet-agents","safety":{"commonSideEffects":[{"rate":"1-5","effect":"Bleeding"},{"rate":"5-15","effect":"Gastrointestinal upset"},{"rate":"5-10","effect":"Dyspepsia"},{"rate":"<0.1","effect":"Thrombotic thrombocytopenic purpura (TTP)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antiplatelet agents work through various mechanisms including inhibition of cyclooxygenase (aspirin), adenosine diphosphate receptor antagonism (clopidogrel, ticlopidine), or phosphodiesterase inhibition (dipyridamole). These drugs prevent platelets from clumping together and forming thrombi, reducing the risk of thrombotic cardiovascular events.","oneSentence":"Antiplatelet agents inhibit platelet aggregation and clot formation by blocking platelet activation pathways.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:17:29.144Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Secondary prevention of myocardial infarction"},{"name":"Ischemic stroke prevention"},{"name":"Peripheral arterial disease"}]},"trialDetails":[{"nctId":"NCT05907694","phase":"NA","title":"Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure","status":"RECRUITING","sponsor":"Josep Rodes-Cabau","startDate":"2024-06-18","conditions":"Patent Foramen Ovale, Cryptogenic Stroke, Older Patients","enrollment":714},{"nctId":"NCT07493603","phase":"PHASE1, PHASE2","title":"A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease","status":"RECRUITING","sponsor":"Xia Liang","startDate":"2026-01-16","conditions":"Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses","enrollment":30},{"nctId":"NCT05387954","phase":"PHASE3","title":"PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-07-07","conditions":"Cryptogenic Ischemic Stroke, Patent Foramen Ovale","enrollment":792},{"nctId":"NCT04957719","phase":"PHASE3","title":"Selatogrel Outcome Study in Suspected Acute Myocardial Infarction","status":"ENROLLING_BY_INVITATION","sponsor":"Viatris Innovation GmbH","startDate":"2021-08-14","conditions":"Acute Myocardial Infarction","enrollment":14000},{"nctId":"NCT06179017","phase":"NA","title":"Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion","status":"RECRUITING","sponsor":"Zhangzhou Municipal Hospital","startDate":"2024-02-07","conditions":"Mild Stroke, Acute Ischemic Stroke, Endovascular Treatment","enrollment":300},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60},{"nctId":"NCT07007143","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-07-31","conditions":"Mitral Regurgitation","enrollment":1032},{"nctId":"NCT06901466","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-06-13","conditions":"Mitral Regurgitation","enrollment":880},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT07445581","phase":"NA","title":"Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Jinggang Xia, MD","startDate":"2026-02-28","conditions":"Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis","enrollment":480},{"nctId":"NCT06037889","phase":"PHASE3","title":"Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2023-11-09","conditions":"Branch Atheromatous Disease","enrollment":516},{"nctId":"NCT07431762","phase":"PHASE4","title":"Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2026-02-01","conditions":"Valve Replacement Surgery","enrollment":1058},{"nctId":"NCT03295773","phase":"","title":"Morphologic Evolution and Remodeling of Intracranial Atherosclerosis: A Longitudinal Study by 3D-rotational Angiography","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2016-08-22","conditions":"Ischemic Stroke, Atheroscleroses, Cerebral","enrollment":140},{"nctId":"NCT03907046","phase":"PHASE3","title":"Anticoagulation in ICH Survivors for Stroke Prevention and Recovery","status":"RECRUITING","sponsor":"Yale University","startDate":"2020-01-28","conditions":"Intracerebral Hemorrhage, Atrial Fibrillation","enrollment":700},{"nctId":"NCT05193019","phase":"","title":"Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación EPIC","startDate":"2022-03-14","conditions":"Ischemic Heart Disease, Acute Coronary Syndrome","enrollment":717},{"nctId":"NCT07243704","phase":"PHASE3","title":"Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Christian Medical College and Hospital, Ludhiana, India","startDate":"2026-02-15","conditions":"Intracerebral Haemorrhage","enrollment":5676},{"nctId":"NCT05832762","phase":"NA","title":"Evaluation of Acute Endovascular Treatment in Symptomatic Isolated Cervical Internal Carotid Artery Occlusion (ETICA)","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-08-19","conditions":"Acute Ischemic Stroke","enrollment":200},{"nctId":"NCT04654052","phase":"PHASE4","title":"VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación EPIC","startDate":"2021-07-02","conditions":"Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease","enrollment":634},{"nctId":"NCT07358416","phase":"","title":"Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Petrovsky National Research Centre of Surgery","startDate":"2025-05-01","conditions":"Thrombosis, Bleeding, Cerebral Hypoxia During and/or Resulting From A Procedure","enrollment":500},{"nctId":"NCT04822363","phase":"EARLY_PHASE1","title":"The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2021-08-20","conditions":"Platelet Activation Testing Before/After Anti-platelet Therapy, Healthy","enrollment":112},{"nctId":"NCT07002476","phase":"PHASE3","title":"Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-06-19","conditions":"Stroke","enrollment":652},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07349875","phase":"PHASE4","title":"Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-01","conditions":"Coronary Artery Disease (CAD)","enrollment":3826},{"nctId":"NCT03968393","phase":"PHASE4","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-06-14","conditions":"Stroke, Atrial Fibrillation","enrollment":2270},{"nctId":"NCT07327853","phase":"","title":"How Often Does the Fecal Test for Occult Blood Turn Positive After Using Blood Thinners?","status":"NOT_YET_RECRUITING","sponsor":"Jordan Collaborating Cardiology Group","startDate":"2026-02-01","conditions":"Gastrointestinal Bleeding, Antiplatelet Agents, Oral Anticoagulant Therapy","enrollment":200},{"nctId":"NCT03687528","phase":"","title":"Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?","status":"RECRUITING","sponsor":"Rennes University Hospital","startDate":"2020-06-15","conditions":"Head Injury Trauma, Emergencies","enrollment":3200},{"nctId":"NCT05671497","phase":"PHASE2, PHASE3","title":"The Effect of Cilostazol on Rheumatoid Arthritis Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-11-01","conditions":"Rheumatoid Arthritis","enrollment":70},{"nctId":"NCT05257824","phase":"PHASE4","title":"Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2022-06-23","conditions":"Aneurysm Cerebral, Endovascular Procedures","enrollment":528},{"nctId":"NCT07290699","phase":"PHASE4","title":"Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2026-01-01","conditions":"STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)","enrollment":2442},{"nctId":"NCT07284199","phase":"NA","title":"CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery.","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-12-15","conditions":"CABG, Aortic Dissection, Valvular Heart Diseases","enrollment":120},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":"Antiphospholipid Syndrome, Arterial Thrombosis","enrollment":150},{"nctId":"NCT07012629","phase":"PHASE3","title":"A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-26","conditions":"Covert Brain Infarction","enrollment":1652},{"nctId":"NCT05752916","phase":"PHASE4","title":"Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-06-02","conditions":"Acute Ischemic Stroke","enrollment":570},{"nctId":"NCT06742931","phase":"NA","title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-04-07","conditions":"Chronic Coronary Syndrome","enrollment":1200},{"nctId":"NCT07039149","phase":"","title":"Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents","status":"RECRUITING","sponsor":"Jordan Collaborating Cardiology Group","startDate":"2025-08-01","conditions":"Major Bleeding, Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)","enrollment":200},{"nctId":"NCT07247071","phase":"","title":"Modifiable Risk Factors for Non-traumatic Subconjunctival Hemorrhage","status":"COMPLETED","sponsor":"Hallym University Kangnam Sacred Heart Hospital","startDate":"2022-12-22","conditions":"Subconjunctival Hemorrhage","enrollment":67},{"nctId":"NCT05860400","phase":"","title":"Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-05-17","conditions":"Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis","enrollment":39},{"nctId":"NCT06845410","phase":"","title":"Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-04-01","conditions":"Coronary Artery Disease, Coronary Artery Disease Progression, Coronary Artery Stenosis","enrollment":120},{"nctId":"NCT07001852","phase":"NA","title":"EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography","status":"RECRUITING","sponsor":"Santiago Ortega Gutierrez","startDate":"2025-10-14","conditions":"Stroke Acute","enrollment":500},{"nctId":"NCT07211854","phase":"","title":"Antithrombotic Strategies in Coronary Artery Dilatations and Aneurysms","status":"COMPLETED","sponsor":"Franck Assayag","startDate":"2024-09-06","conditions":"Coronary Artery Dilatations and Aneursyms","enrollment":51},{"nctId":"NCT07208695","phase":"","title":"Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation","status":"NOT_YET_RECRUITING","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2025-10-01","conditions":"Oral Antiplatele, Anticoagulant Drugs, Lower Extremity Varicose Veins","enrollment":40},{"nctId":"NCT06665919","phase":"NA","title":"The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models","status":"COMPLETED","sponsor":"Vistamedi Ltd.","startDate":"2023-06-15","conditions":"Coronary Artery Disease, Clopidogrel Resistance, Coronary Thrombosis","enrollment":283},{"nctId":"NCT04694248","phase":"NA","title":"Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2021-11-03","conditions":"Deep Vein Thrombosis, Iliac Vein Thrombosis, Iliac Vein Obstruction","enrollment":172},{"nctId":"NCT06933056","phase":"EARLY_PHASE1","title":"Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2025-09-02","conditions":"Platelet Function and Reactivity Tests","enrollment":20},{"nctId":"NCT07168278","phase":"PHASE3","title":"Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2025-11-01","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Tenecteplase","enrollment":794},{"nctId":"NCT05476991","phase":"PHASE3","title":"Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-17","conditions":"Stroke, Stroke, Ischemic, Atherosclerosis","enrollment":2800},{"nctId":"NCT07153744","phase":"PHASE4","title":"Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Hutchison Pharmaceuticals Limited","startDate":"2025-09-01","conditions":"Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)","enrollment":9588},{"nctId":"NCT04481997","phase":"","title":"Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI","status":"COMPLETED","sponsor":"Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA","startDate":"2021-01-11","conditions":"Type2 Diabetes Mellitus, Coronary Heart Disease","enrollment":1000},{"nctId":"NCT07125651","phase":"","title":"Gastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-09-01","conditions":"Gastro Intestinal Bleeding, Ischaemic Heart Diseases, Antiplatelet Drugs","enrollment":112},{"nctId":"NCT05004233","phase":"NA","title":"Transmission Electron Microscopy Images for Platelet Ultrastructural Criteria Before and After the Onset of an Antiplatelet Agent","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2024-12-13","conditions":"Ischemic Stroke","enrollment":50},{"nctId":"NCT07089030","phase":"NA","title":"Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy","status":"RECRUITING","sponsor":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec","startDate":"2023-06-06","conditions":"Obscure Gastrointestinal Bleeding, Iron-Deficiency Anemia, Antithrombotic Therapy","enrollment":20},{"nctId":"NCT05631769","phase":"PHASE4","title":"HOST - DAPT Duration According the Bleeding Risk","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2020-07-24","conditions":"Coronary Artery Disease, Acute Myocardial Infarction, Stable Angina","enrollment":4900},{"nctId":"NCT04410341","phase":"PHASE1, PHASE2","title":"The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2020-05-01","conditions":"Major Depressive Disorder","enrollment":""},{"nctId":"NCT04932603","phase":"","title":"Multidisciplinary Team Approach to Prescribe Antithrombotic Therapy in Older People With Atrial Fibrillation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-05-29","conditions":"Atrial Fibrillation","enrollment":833},{"nctId":"NCT05643651","phase":"PHASE4","title":"Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-06-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm","enrollment":100},{"nctId":"NCT06269432","phase":"PHASE4","title":"Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE（PATH-STROKE）","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2023-01-01","conditions":"Ischemic Stroke, Antiplatelet Drug","enrollment":1020},{"nctId":"NCT06930092","phase":"NA","title":"RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-07-01","conditions":"Ischemic Cardiomyopathy","enrollment":158},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT07016854","phase":"NA","title":"Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion","status":"RECRUITING","sponsor":"Sir Run Run Shaw Hospital","startDate":"2025-06","conditions":"Stroke, Acute Ischemic","enrollment":140},{"nctId":"NCT03978988","phase":"NA","title":"Thrombectomy In TANdem Occlusion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2020-04-29","conditions":"Carotid Artery Diseases, Thrombectomy, Tandem Occlusion","enrollment":432},{"nctId":"NCT06993636","phase":"","title":"Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-01-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm, Rivaroxaban","enrollment":60},{"nctId":"NCT02596126","phase":"PHASE3","title":"Secondary Prevention of Cardiovascular Disease in the Elderly Trial","status":"COMPLETED","sponsor":"Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III","startDate":"2016-07","conditions":"Myocardial Infarction, Cardiovascular Disease","enrollment":2499},{"nctId":"NCT06986369","phase":"PHASE4","title":"Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular Diseases","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2021-05-04","conditions":"Atherosclerosis, Coronary","enrollment":140},{"nctId":"NCT06953622","phase":"","title":"Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale","status":"RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2024-01-01","conditions":"Migraine, Patent Foramen Ovale","enrollment":330},{"nctId":"NCT06943586","phase":"NA","title":"Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-04-09","conditions":"Stroke, Transient Ischemic Attack (TIA)","enrollment":200},{"nctId":"NCT02561000","phase":"PHASE2","title":"Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2016-05-27","conditions":"Arterial Occlusive Diseases, Coronary Artery Disease, Coronary Disease","enrollment":100},{"nctId":"NCT04820972","phase":"NA","title":"Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2021-05-01","conditions":"Spontaneous Intracerebral Hemorrhage","enrollment":269},{"nctId":"NCT06715007","phase":"","title":"Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-12-20","conditions":"Stroke, Ischemic, Small Vessel Cerebrovascular Disease, White Matter Hyperintensity","enrollment":300},{"nctId":"NCT05899582","phase":"NA","title":"Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-09-15","conditions":"Symptomatic Chronic Middle Cerebral Artery Occlusion, Infarction, Middle Cerebral Artery","enrollment":420},{"nctId":"NCT06899399","phase":"NA","title":"Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-10-18","conditions":"Asymptomatic Carotid Artery Stenosis","enrollment":982},{"nctId":"NCT04522102","phase":"PHASE3","title":"Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase","status":"COMPLETED","sponsor":"The George Institute for Global Health, China","startDate":"2021-09-03","conditions":"Intracerebral Hemorrhage","enrollment":80},{"nctId":"NCT06736353","phase":"","title":"Effect of Classic Secondary Prevention in Type 2 MI: A Target Trial Emulation Study","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2010-09-03","conditions":"Myocardial Infarction Type 2","enrollment":14000},{"nctId":"NCT06541691","phase":"NA","title":"Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease","status":"RECRUITING","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2024-03-06","conditions":"Atherosclerotic Cardiovascular Disease, Coronary Artery Disease, Ischemic Heart Disease","enrollment":3000},{"nctId":"NCT06881901","phase":"","title":"Antiplatelet Strategy for CCS Patients Undergoing CABG","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-01-01","conditions":"Chronic Coronary Syndrome, Coronary Artery Bypass Graft CABG","enrollment":29898},{"nctId":"NCT04347200","phase":"","title":"REGistry of Long-term AnTithrombotic TherApy-1","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2015-01-15","conditions":"Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Peripheral Artery Disease","enrollment":2000},{"nctId":"NCT06877390","phase":"NA","title":"Effect of Enhanced External Counterpulsation","status":"COMPLETED","sponsor":"Chongming Hospital Affiliated to Shanghai University of Health & Medicine Sciences","startDate":"2023-11-01","conditions":"Enhanced External Counterpulsation (EECP), Acute Myocardial Infarction (AMI), Drug-coated Balloon","enrollment":60},{"nctId":"NCT06281041","phase":"","title":"Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2013-01-01","conditions":"Coronary Artery Disease, Coronary Artery Stenosis","enrollment":4657},{"nctId":"NCT06510634","phase":"","title":"Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion","status":"ENROLLING_BY_INVITATION","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-06-01","conditions":"Stroke, Ischemic","enrollment":236},{"nctId":"NCT06850207","phase":"","title":"Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with PAD：Phase II","status":"NOT_YET_RECRUITING","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2025-02-28","conditions":"Peripheral Arterial Disease(PAD)","enrollment":6000},{"nctId":"NCT03186729","phase":"PHASE4","title":"Study of Antithrombotic Treatment After IntraCerebral Haemorrhage","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2018-07-01","conditions":"Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation","enrollment":134},{"nctId":"NCT06723145","phase":"PHASE4","title":"Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation","status":"RECRUITING","sponsor":"Kyoto University","startDate":"2025-01-20","conditions":"Antiplatelet Agents, Perioperative Care","enrollment":1200},{"nctId":"NCT03243175","phase":"PHASE3","title":"Avoiding Anticoagulation After IntraCerebral Haemorrhage","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2019-01-17","conditions":"Intracerebral Hemorrhage, Atrial Fibrillation, Microhaemorrhage","enrollment":300},{"nctId":"NCT02398656","phase":"PHASE3","title":"A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2015-04-01","conditions":"Stroke, Acute","enrollment":1274},{"nctId":"NCT06788626","phase":"PHASE3","title":"Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment","status":"NOT_YET_RECRUITING","sponsor":"Wei Hu","startDate":"2025-02","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Neuroprotective Drugs","enrollment":390},{"nctId":"NCT03996772","phase":"PHASE3","title":"PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-06-03","conditions":"Atrial Fibrillation, Intracerebral Hemorrhage","enrollment":319},{"nctId":"NCT06588231","phase":"NA","title":"Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-10-17","conditions":"Coronary Heart Disease","enrollment":200},{"nctId":"NCT03062319","phase":"PHASE4","title":"Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis","status":"TERMINATED","sponsor":"National Hospital Organization Osaka National Hospital","startDate":"2017-04-06","conditions":"Ischemic Stroke, Atrial Fibrillation, Atherothrombosis","enrollment":321},{"nctId":"NCT00291525","phase":"NA","title":"Randomized On-X Anticoagulation Trial","status":"COMPLETED","sponsor":"On-X Life Technologies, Inc.","startDate":"2006-06-06","conditions":"Heart Valve Disease","enrollment":977},{"nctId":"NCT06698874","phase":"NA","title":"MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2024-12-01","conditions":"Gastrointestinal Bleeding, Antiplatelet Therapy","enrollment":204},{"nctId":"NCT06683300","phase":"","title":"Drug Eluting Stenting and Short Dual Antiplatelet Therapy for Preventing Recurrent Stroke in Vertebral Stenosis Registry Study","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-11","conditions":"Vertebral Artery Stenosis","enrollment":520},{"nctId":"NCT06680180","phase":"","title":"Fibrinolysis Resistance in Infection and Trauma","status":"RECRUITING","sponsor":"Anders Aneman","startDate":"2024-06-01","conditions":"Sepsis and Septic Shock, Trauma","enrollment":150},{"nctId":"NCT06587347","phase":"PHASE2, PHASE3","title":"Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-20","conditions":"Acute Stroke, Ischemic Stroke, Acute, Cerebral Infarction","enrollment":302},{"nctId":"NCT05995600","phase":"PHASE4","title":"Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2024-02-20","conditions":"Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack","enrollment":200},{"nctId":"NCT05419583","phase":"NA","title":"Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2022-11-14","conditions":"Myocardial Infarction Type 2","enrollment":60},{"nctId":"NCT05507645","phase":"PHASE3","title":"ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2022-11-15","conditions":"Ischemic Stroke, Mild, Thrombosis","enrollment":1446},{"nctId":"NCT06558942","phase":"NA","title":"Incisional Negative Pressure Therapy to Prevent Animal Induced Wound Infection","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2024-08-20","conditions":"Injury Caused by Animal Bites, Wound Infection","enrollment":60},{"nctId":"NCT06549582","phase":"NA","title":"Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients","status":"NOT_YET_RECRUITING","sponsor":"Yan Zhu","startDate":"2024-10","conditions":"Cerebral Infarction, Chinese Herbal Medicine, Clinical Trial","enrollment":160},{"nctId":"NCT04853719","phase":"PHASE4","title":"Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients","status":"COMPLETED","sponsor":"Science Valley Research Institute","startDate":"2021-04-20","conditions":"Peripheral Artery Disease, Intermittent Claudication","enrollment":88},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"CHEST PAIN"},{"count":2,"reaction":"DIZZINESS"},{"count":1,"reaction":"ABDOMINAL DISTENSION"},{"count":1,"reaction":"ACUTE KIDNEY INJURY"},{"count":1,"reaction":"ACUTE LEFT VENTRICULAR FAILURE"},{"count":1,"reaction":"ANGINA PECTORIS"},{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"BALANCE DISORDER"},{"count":1,"reaction":"BUNDLE BRANCH BLOCK LEFT"},{"count":1,"reaction":"CEREBROVASCULAR ACCIDENT"}],"_approvalHistory":[],"publicationCount":6280,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Aspirin","Clopidogrel","aspirin","clopidogrel","lysine acetylsalicylate or equivalent"],"phase":"marketed","status":"active","brandName":"Antiplatelet Agents","genericName":"Antiplatelet Agents","companyName":"Beijing Tiantan Hospital","companyId":"beijing-tiantan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antiplatelet agents inhibit platelet aggregation and clot formation by blocking platelet activation pathways. Used for Acute coronary syndrome, Secondary prevention of myocardial infarction, Ischemic stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}